Stewart Cramer
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Skin Neoplasms | 18 | 1980 | 97 |
Why?
| Melanoma | 14 | 1982 | 87 |
Why?
| Melanocytes | 17 | 1984 | 12 |
Why?
| Uterine Neoplasms | 12 | 1980 | 52 |
Why?
| Leiomyoma | 12 | 1980 | 34 |
Why?
| Nevus, Pigmented | 11 | 1984 | 10 |
Why?
| Myometrium | 7 | 1980 | 13 |
Why?
| Nevus, Epithelioid and Spindle Cell | 3 | 1998 | 2 |
Why?
| Epidermis | 5 | 1981 | 30 |
Why?
| Diagnostic Errors | 4 | 1993 | 73 |
Why?
| Pathology, Surgical | 2 | 2004 | 4 |
Why?
| Cell Transformation, Neoplastic | 2 | 2005 | 86 |
Why?
| Humans | 69 | 1979 | 1858 |
Why?
| Purpura, Thrombocytopenic | 2 | 1996 | 11 |
Why?
| Diagnosis, Differential | 13 | 1980 | 403 |
Why?
| Nevus | 6 | 1981 | 11 |
Why?
| Peripheral Nervous System Neoplasms | 2 | 1989 | 8 |
Why?
| Ovarian Neoplasms | 4 | 1987 | 64 |
Why?
| Pregnancy Complications, Neoplastic | 2 | 1987 | 24 |
Why?
| Observer Variation | 5 | 1993 | 103 |
Why?
| Cell Differentiation | 11 | 1984 | 262 |
Why?
| Stem Cells | 2 | 1991 | 107 |
Why?
| Precancerous Conditions | 1 | 2008 | 29 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2007 | 16 |
Why?
| Placenta Diseases | 1 | 2007 | 11 |
Why?
| Neoplasm Seeding | 1 | 2007 | 6 |
Why?
| Female | 35 | 1980 | 1646 |
Why?
| Arteries | 1 | 2007 | 56 |
Why?
| Cell Communication | 1 | 2008 | 72 |
Why?
| Leiomyomatosis | 1 | 2007 | 10 |
Why?
| Fetal Death | 1 | 2007 | 30 |
Why?
| Prenatal Diagnosis | 1 | 2007 | 31 |
Why?
| Placenta | 1 | 2007 | 48 |
Why?
| Keratinocytes | 4 | 1990 | 36 |
Why?
| Endometrial Hyperplasia | 1 | 2005 | 6 |
Why?
| Keratins | 4 | 1987 | 27 |
Why?
| Dysplastic Nevus Syndrome | 1 | 2005 | 5 |
Why?
| Pathology, Clinical | 1 | 2005 | 5 |
Why?
| Cervix Uteri | 1 | 2005 | 38 |
Why?
| Bone Neoplasms | 1 | 2007 | 83 |
Why?
| Adenocarcinoma, Mucinous | 2 | 1989 | 20 |
Why?
| Hyperplasia | 4 | 1995 | 55 |
Why?
| Dermatology | 1 | 2005 | 11 |
Why?
| Uterine Diseases | 1 | 2003 | 11 |
Why?
| Adult | 19 | 1979 | 1321 |
Why?
| Paget Disease, Extramammary | 1 | 2002 | 7 |
Why?
| Referral and Consultation | 1 | 2004 | 134 |
Why?
| Reproducibility of Results | 5 | 1988 | 392 |
Why?
| Menopause | 3 | 1992 | 27 |
Why?
| Immunohistochemistry | 5 | 1989 | 356 |
Why?
| Premenopause | 1 | 2000 | 16 |
Why?
| Carcinoma | 4 | 1979 | 109 |
Why?
| Postmenopause | 1 | 2000 | 27 |
Why?
| Pathology | 2 | 1988 | 25 |
Why?
| Leuprolide | 1 | 1998 | 7 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 1998 | 23 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 1998 | 30 |
Why?
| Cell Nucleus | 3 | 1995 | 169 |
Why?
| Keratoacanthoma | 3 | 1981 | 3 |
Why?
| Actinin | 1 | 1996 | 6 |
Why?
| Antigens, CD29 | 1 | 1996 | 8 |
Why?
| Breast Neoplasms | 4 | 1981 | 186 |
Why?
| Integrins | 1 | 1996 | 35 |
Why?
| Middle Aged | 13 | 1980 | 1166 |
Why?
| Multiple Endocrine Neoplasia Type 1 | 1 | 1996 | 5 |
Why?
| Neoplasm Metastasis | 4 | 1984 | 112 |
Why?
| Biopsy, Needle | 4 | 1980 | 94 |
Why?
| Shock, Septic | 1 | 1995 | 40 |
Why?
| World Health Organization | 2 | 1987 | 19 |
Why?
| Pulmonary Embolism | 1 | 1995 | 48 |
Why?
| Thyroid Neoplasms | 2 | 1979 | 43 |
Why?
| Carcinoma, Medullary | 1 | 1994 | 4 |
Why?
| Carcinoma, Squamous Cell | 3 | 1980 | 112 |
Why?
| Microfilament Proteins | 1 | 1995 | 41 |
Why?
| Neoplasm Invasiveness | 2 | 2002 | 105 |
Why?
| Streptococcal Infections | 1 | 1995 | 54 |
Why?
| Pregnancy | 3 | 1987 | 457 |
Why?
| Aged | 7 | 1988 | 992 |
Why?
| Mast Cells | 2 | 1982 | 31 |
Why?
| Reference Standards | 1 | 1991 | 35 |
Why?
| Adenocarcinoma | 2 | 1981 | 167 |
Why?
| Neoplasms | 1 | 1999 | 239 |
Why?
| Terminology as Topic | 2 | 1997 | 81 |
Why?
| Uterine Cervical Neoplasms | 3 | 1999 | 55 |
Why?
| Practice Guidelines as Topic | 2 | 2000 | 174 |
Why?
| Ganglia, Spinal | 1 | 2009 | 21 |
Why?
| Forehead | 1 | 1989 | 4 |
Why?
| Nerve Endings | 1 | 1989 | 12 |
Why?
| Schwann Cells | 1 | 1989 | 21 |
Why?
| Antigens, Neoplasm | 1 | 1990 | 56 |
Why?
| Clinical Competence | 1 | 1991 | 130 |
Why?
| Parotid Neoplasms | 1 | 1988 | 9 |
Why?
| Neoplasm Recurrence, Local | 2 | 1982 | 118 |
Why?
| Nervous System | 1 | 1988 | 52 |
Why?
| ADAM Proteins | 1 | 2007 | 4 |
Why?
| Skin Pigmentation | 1 | 1988 | 8 |
Why?
| Hypertension, Malignant | 1 | 2007 | 6 |
Why?
| Purpura, Thrombotic Thrombocytopenic | 1 | 2007 | 9 |
Why?
| Plasma Exchange | 1 | 2007 | 11 |
Why?
| United States | 3 | 1995 | 604 |
Why?
| Plasmapheresis | 1 | 2007 | 20 |
Why?
| Parotid Gland | 1 | 1988 | 20 |
Why?
| Pre-Eclampsia | 1 | 2007 | 18 |
Why?
| Fibrosis | 2 | 1996 | 46 |
Why?
| Eccrine Glands | 1 | 2007 | 6 |
Why?
| Uterine Rupture | 1 | 2007 | 4 |
Why?
| Placenta Accreta | 1 | 1987 | 6 |
Why?
| Prednisone | 2 | 1980 | 80 |
Why?
| Hysterectomy | 1 | 2007 | 23 |
Why?
| Drug Therapy, Combination | 2 | 1980 | 189 |
Why?
| Pregnancy Trimester, First | 1 | 2007 | 23 |
Why?
| Hematopoietic Stem Cells | 1 | 2009 | 69 |
Why?
| Reoperation | 1 | 2007 | 106 |
Why?
| Cesarean Section | 1 | 2007 | 42 |
Why?
| Membrane Glycoproteins | 1 | 1990 | 154 |
Why?
| Intercellular Junctions | 1 | 2006 | 17 |
Why?
| Skin Diseases | 1 | 1987 | 69 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2007 | 82 |
Why?
| Aged, 80 and over | 3 | 1995 | 602 |
Why?
| Consensus Development Conferences as Topic | 1 | 2005 | 6 |
Why?
| Nerve Growth Factors | 3 | 1979 | 43 |
Why?
| Cell Adhesion | 1 | 2006 | 113 |
Why?
| Telepathology | 1 | 2004 | 2 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 427 |
Why?
| Remote Consultation | 1 | 2004 | 7 |
Why?
| Photomicrography | 1 | 2003 | 7 |
Why?
| Age Factors | 2 | 1996 | 480 |
Why?
| Societies, Medical | 1 | 2005 | 90 |
Why?
| Quality Control | 2 | 2000 | 54 |
Why?
| Vaginal Smears | 2 | 2000 | 31 |
Why?
| Neoplastic Stem Cells | 2 | 1987 | 21 |
Why?
| Cell Division | 1 | 1985 | 273 |
Why?
| Adolescent | 3 | 1981 | 892 |
Why?
| Fasciitis | 1 | 1982 | 10 |
Why?
| Lymphangiomyoma | 1 | 1981 | 1 |
Why?
| Tomography, X-Ray Computed | 1 | 2007 | 322 |
Why?
| Eosinophilia | 1 | 1982 | 24 |
Why?
| Neurilemma | 1 | 1981 | 1 |
Why?
| Lymphoproliferative Disorders | 1 | 1981 | 23 |
Why?
| Child | 2 | 1997 | 750 |
Why?
| Lupus Erythematosus, Discoid | 1 | 1981 | 4 |
Why?
| Nail Diseases | 1 | 1981 | 7 |
Why?
| Neoplasms, Multiple Primary | 1 | 1981 | 39 |
Why?
| Cell Biology | 1 | 2000 | 5 |
Why?
| Keratosis | 2 | 1989 | 9 |
Why?
| Mass Screening | 2 | 2000 | 126 |
Why?
| Laboratories | 1 | 2000 | 21 |
Why?
| Silicone Oils | 1 | 2000 | 1 |
Why?
| Hypergammaglobulinemia | 1 | 2000 | 5 |
Why?
| Silicone Gels | 1 | 2000 | 6 |
Why?
| H-2 Antigens | 1 | 2000 | 12 |
Why?
| Cell Size | 1 | 2000 | 68 |
Why?
| Professional Competence | 1 | 2000 | 37 |
Why?
| Macrophage Activation | 1 | 2000 | 42 |
Why?
| Lupus Erythematosus, Systemic | 1 | 1981 | 53 |
Why?
| Treatment Outcome | 1 | 2007 | 662 |
Why?
| Gastrointestinal Neoplasms | 1 | 1999 | 20 |
Why?
| Animals | 4 | 1987 | 1032 |
Why?
| Prostate | 1 | 1981 | 55 |
Why?
| Great Britain | 1 | 1999 | 49 |
Why?
| Lung Neoplasms | 2 | 1980 | 160 |
Why?
| Quality Assurance, Health Care | 1 | 1999 | 83 |
Why?
| Infant | 1 | 2003 | 464 |
Why?
| Receptors, Collagen | 1 | 1996 | 1 |
Why?
| Child, Preschool | 1 | 2003 | 555 |
Why?
| Hodgkin Disease | 1 | 1999 | 46 |
Why?
| Skin | 1 | 1998 | 177 |
Why?
| Uterus | 2 | 1980 | 49 |
Why?
| Fatal Outcome | 1 | 1996 | 86 |
Why?
| Canada | 1 | 1995 | 60 |
Why?
| Prostatic Neoplasms | 1 | 1981 | 120 |
Why?
| Fibroblast Growth Factor 2 | 1 | 1994 | 49 |
Why?
| Neurons | 1 | 1981 | 195 |
Why?
| Histological Techniques | 1 | 1993 | 22 |
Why?
| Neoplasm Proteins | 1 | 1995 | 110 |
Why?
| Cell Movement | 1 | 1995 | 163 |
Why?
| Receptors, Estrogen | 2 | 1980 | 44 |
Why?
| Smoking | 1 | 1995 | 153 |
Why?
| Mucin-1 | 1 | 1990 | 12 |
Why?
| Thyroglobulin | 1 | 1989 | 7 |
Why?
| Calcitonin | 1 | 1989 | 23 |
Why?
| Biological Markers | 1 | 1992 | 263 |
Why?
| Breast Diseases | 1 | 1989 | 19 |
Why?
| Staining and Labeling | 1 | 1989 | 101 |
Why?
| Immunoglobulin G | 2 | 1982 | 192 |
Why?
| Axons | 1 | 1989 | 67 |
Why?
| Male | 5 | 1979 | 1558 |
Why?
| Neoplasm Staging | 1 | 1987 | 126 |
Why?
| Receptors, Progesterone | 1 | 1985 | 28 |
Why?
| Progesterone | 1 | 1985 | 42 |
Why?
| Estradiol | 1 | 1985 | 78 |
Why?
| Cell Survival | 1 | 1985 | 230 |
Why?
| Lentigo | 1 | 1982 | 2 |
Why?
| Sunlight | 1 | 1982 | 12 |
Why?
| Scleroderma, Systemic | 1 | 1982 | 13 |
Why?
| Eosinophils | 1 | 1982 | 30 |
Why?
| Insulin | 1 | 1985 | 129 |
Why?
| Cytotoxicity, Immunologic | 1 | 1982 | 54 |
Why?
| Pemphigus | 1 | 1980 | 6 |
Why?
| Solitary Pulmonary Nodule | 1 | 1980 | 3 |
Why?
| Antigens | 1 | 1981 | 66 |
Why?
| Terpenes | 1 | 2000 | 10 |
Why?
| Workload | 1 | 2000 | 37 |
Why?
| Antibodies, Antinuclear | 1 | 2000 | 23 |
Why?
| Microscopy, Electron | 1 | 1981 | 178 |
Why?
| Macrophages, Peritoneal | 1 | 2000 | 12 |
Why?
| Breast Implants | 1 | 2000 | 9 |
Why?
| Fingers | 1 | 1981 | 37 |
Why?
| Organoids | 1 | 1979 | 8 |
Why?
| Immunoglobulin M | 1 | 2000 | 82 |
Why?
| Prostatectomy | 1 | 1981 | 29 |
Why?
| Cyclophosphamide | 1 | 1980 | 84 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 118 |
Why?
| Cytoplasm | 1 | 2000 | 108 |
Why?
| Interleukin-1 | 1 | 2000 | 109 |
Why?
| Cells, Cultured | 1 | 1985 | 447 |
Why?
| Immunosuppressive Agents | 1 | 2000 | 103 |
Why?
| Interleukin-6 | 1 | 2000 | 146 |
Why?
| Kidney | 1 | 2000 | 223 |
Why?
| Palpation | 1 | 1989 | 12 |
Why?
| Cytodiagnosis | 1 | 1989 | 17 |
Why?
| Mice | 1 | 2000 | 623 |
Why?
| Breast | 1 | 1989 | 40 |
Why?
| Mammography | 1 | 1989 | 33 |
Why?
| Cheek | 1 | 1980 | 20 |
Why?
| Amyloid | 1 | 1980 | 16 |
Why?
| Lung | 1 | 1980 | 233 |
Why?
|
|
Cramer's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
